Literature DB >> 30201014

Yellow nail syndrome with chylothorax after coronary artery bypass grafting.

Sarah Waliany1, Julia Chandler2, David Hovsepian3, Jack Boyd4, Natalie Lui5,6.   

Abstract

BACKGROUND: Yellow nail syndrome is a rare condition considered secondary to functional anomalies of lymphatic drainage. Yellow nail syndrome is diagnosed through the triad of intrathoracic findings (30% being pleural effusions), nail discoloration, and lymphedema, with any two features sufficient for diagnosis. We report the second case of post-operative yellow nail syndrome. CASE
PRESENTATION: After coronary artery bypass grafting, our patient presented with chylothorax on post-operative day 13 and yellow toenail discoloration on post-operative day 28, diagnosing yellow nail syndrome. Initial conservative management with pigtail catheter drainage and low-fat diet with medium-chain triglycerides reduced chylous drainage from 350 mL/day on post-operative day 14 to < 100 mL/day on post-operative day 17. However, by post-operative day 18, drainage returned to 350 mL/day that persisted despite attempts to readjust the catheter position, replacement of catheter with chest tube, and transition to total parenteral nutrition and octreotide while nil per os. Lymphangiogram on post-operative day 32 did not identify the thoracic duct or cisterna chyli, precluding embolization. Talc and doxycycline pleurodeses performed on post-operative days 33 and 38, respectively, resolved his chylothorax and nail discoloration.
CONCLUSIONS: Both yellow nail syndrome and chylothorax as a complication of coronary artery bypass grafting are rare entities. The proposed mechanism of post-operative chylothorax is iatrogenic injury to thoracic duct or collateral lymphatic vessels. Diagnosing yellow nail syndrome in patients with post-operative chylothorax (through co-existing yellow nail discoloration and/or lymphedema) may suggest predisposition to impaired lymphatic drainage, portending a difficult recovery and potentially indicating need for surgical management.

Entities:  

Keywords:  Coronary artery bypass grafting complications; Post-operative chylothorax; Yellow nail syndrome

Mesh:

Substances:

Year:  2018        PMID: 30201014      PMCID: PMC6131875          DOI: 10.1186/s13019-018-0784-8

Source DB:  PubMed          Journal:  J Cardiothorac Surg        ISSN: 1749-8090            Impact factor:   1.637


Background

Yellow nail syndrome (YNS) is a rare condition of unclear etiology considered secondary to functional anomalies of lymphatic drainage. YNS is characterized by the triad of nail changes, intrathoracic findings (30% being pleural effusions), and lymphedema, with only two of the triad elements required for diagnosis (typically nail discoloration with one of the other findings) [1]. Most cases of YNS have been associated with malignancies, especially lymphoma; autoimmune disorders; immunodeficiencies; endocrine diseases; and others. We report the second case, to our knowledge, of YNS associated with surgery; the first reported case of post-operative YNS was also diagnosed after coronary artery bypass grafting (CABG). We also review the literature on the 41 prior reported cases of chylothorax diagnosed after CABG.

Case presentation

A 62-year-old man with coronary artery disease underwent four-vessel CABG including left internal thoracic artery (ITA) to left anterior descending artery. The patient was discharged on postoperative day (POD) 6 after an uneventful postoperative course with low chest tube output and trace pleural effusions. On POD 13, the patient was readmitted after four days of moderate chest pain and exertional dyspnea. Diminished respiratory sounds were noted over the full left lung field. Chest radiograph confirmed a large left pleural effusion (Fig. 1). A left pigtail catheter drained 2.3 l of milky fluid with a triglyceride level of 1604 mg/dL, diagnosing chylothorax.
Fig. 1

Chest radiograph detected a large pleural effusion over the left lung field on post-operative day 13 after coronary artery bypass grafting

Chest radiograph detected a large pleural effusion over the left lung field on post-operative day 13 after coronary artery bypass grafting Conservative management was attempted with continued catheter drainage and initiation of a low-fat diet with medium-chain triglycerides on POD 14. Drainage gradually decreased over the next three days to < 100 ml/day, but by POD 18, drainage increased to 350 mL/day that continued for two days despite attempts to readjust the catheter position. On POD 20, the pigtail catheter was replaced with a chest tube, and the patient was transitioned to total parenteral nutrition (TPN) and octreotide while nil per os, but chest tube drainage persisted at 200–360 ml/day. On POD 28, the patient noted new, bilateral yellow toenail discoloration (Fig. 2). The yellow nail discoloration was not associated with any disfiguring features such as nail thickening or separation from nail bed. No lymphedema was found. Presence of yellow nails and chylothorax resulted in diagnosis of YNS.
Fig. 2

On post-operative day 28 after coronary artery bypass grafting, the patient noted yellow toenail discoloration not present prior to admission

On post-operative day 28 after coronary artery bypass grafting, the patient noted yellow toenail discoloration not present prior to admission Lymphangiogram on POD 32 noted well-opacified pelvic lymphatic channels, but cisterna chyli and thoracic duct were not identified (Fig. 3), precluding embolization. Tiny droplets of lipiodol were present in the left pleural space, but the leak location could not be identified.
Fig. 3

On post-operative day 32, lymphangiogram detected patchy areas of contrast (lipiodol) accumulation in the mediastinum (a) without identifying a clearly defined point of lymphatic injury and without identifying the cisterna chyli or thoracic duct (precluding embolization) even though the pelvic lymphatic channels were well-opacified (b). Sternal wires and left chest tube were also visible

On post-operative day 32, lymphangiogram detected patchy areas of contrast (lipiodol) accumulation in the mediastinum (a) without identifying a clearly defined point of lymphatic injury and without identifying the cisterna chyli or thoracic duct (precluding embolization) even though the pelvic lymphatic channels were well-opacified (b). Sternal wires and left chest tube were also visible On POD 33, thoracoscopic left pleurodesis was performed using aerosolized talc (4 g). Prior to talc administration, half-and-half (300 mL) was administered via nasogastric tube, but no chyle leak was found on thoracoscopic examination after two hours. Since lymphangiogram did not identify a thoracic duct, thoracic duct ligation was not attempted. Five days after pleurodesis, since chest tube output remained high (> 200–300 ml/day), doxycycline pleurodesis was performed via existing chest tube. Output subsequently decreased, allowing transition to low-fat diet seven days later and discharge home two days after that. At 2- and 8-week follow-ups, chest radiograph showed trace pleural effusion with no recurrence of chylothorax. Although still on a low-fat diet at both visits, the patient was gradually increasing fat intake. Yellow toenail discoloration had resolved by the 8-week follow-up.

Discussion

YNS is diagnosed clinically through the triad of characteristic nail changes, intrathoracic findings (30% being pleural effusions), and lymphedema. Presence of any two features (typically nail discoloration with another finding) is sufficient for diagnosis [1], with the full triad observed in one-third of cases [2]. About 30% of YNS-associated pleural effusions are chylothoraces [3]. Since the first report in 1964 [4], fewer than 400 cases of YNS have been described in the literature. The etiology remains unknown, with prior associations including malignancies (especially lymphoma), immunodeficiency disorders, tuberculosis, diabetes mellitus, thyroid dysfunction, Guillan-Barré syndrome, and others. This is the second report of YNS associated with surgery; the first reported case was also diagnosed after CABG [5]. Although debated, the pathophysiology of YNS is attributed to functional lymphatic defects, with lymphangiogram and lymphoscintigraphy findings of hypoplastic lymphatic vessels [4] and reduced lymphatic drainage in extremities [6]. Nail discoloration results from lipofuscin pigment from oxidation of lipid precursors in soft tissue lymph collections. The conditions associated with YNS are considered to be second insults causing functionally anomalous lymphatics to present clinically through intrathoracic findings, nail changes, and/or edema. Our report indicates that traumatic disruption of lymphatic vessels may be another trigger causing functionally anomalous lymphatics to manifest clinically as YNS. Intra-operative damage to thoracic duct or other lymphatic tributaries may have overwhelmed the lymphatic network, causing accumulation of chyle in the pleural space as chylothorax and in lower extremity soft tissues manifesting as yellow nails. Although our patient did not have visible lymphedema, a previous study showed that patients with YNS without edema still had significantly reduced lymphatic drainage in lower extremities on lymphoscintigraphy compared with control patients [6]; this suggests that our patient’s lymph collection may have been sufficient to cause lipofuscin accumulation but not edema. Post-CABG chylothorax is also rare, with 41 other reported cases (Table 1). The proposed mechanism is iatrogenic injury to the thoracic duct or collateral lymphatic vessels. A strong association exists with left ITA harvesting (involving 81.0% of the 42 cases including ours) due to close proximity between the left ITA origin and thoracic duct. Another risk factor is use of electrocautery during harvesting; due to low protein in lymph (compared with blood), electrocautery of lymphatics increases risk of leakage rather than achieving lymphostasis [7].
Table 1

Reported cases of chylothorax diagnosed after coronary artery bypass grafting

ReferenceYearSexAgeProcedureL ITAR ITAChylothorax sitePODOutcome with conservative txOctreotide?Surgical tx
Weber [10]1981M55CABGYesNoL & M2Resolved after 12dNoNone
Zakhour [11]1981M73CABGYesNoL90Resolved after 21dNoNone
Zakhour [11]1981M59CABGNoNoL & M2Resolved after 5dNoNone
Kshettry [12]1981M51CABGNoNoL30Resolved after 4dNoNone
Teba [13]1985F51CABG/MVRNoNoL7Resolved after 17dNoNone
Di Lello [14]1987M53CABGYesNoL9Failed after 31dNoL thoracotomy-fibrin glue
Czarnecki [15]1988F61CABGYesYesR42Failed after 10dNoR thoracotomy-ligation at diaphragm
Chaiyaroji [16]1991F69CABGYesNoL6Failed after 18dNoL thoracotomy-ligation at injury
Inderbitzi [17]1992M69CABG/RedoUKUKL2Failed after 21dNoLeft VATS - fibrin glue
Bogers [18]1993M41CABGYesNoL1Failed after 35dNoL thoracotomy-ligation at injury
Janssen [19]1994M58CABGYesNoL35Failed after 14dNoL VATS-ligation at injury
Davies [20]1994M48CABGYesNoL21Resolved after 28dNoNone
Wood [21]1994M69CABGYesNoL3Failed after 7dNoL VATS-ligation at injury
Smith [22]1994M60CABGYesNoL14Resolved after 15dNoNone
Smith [22]1994M47CABGYesNoL7Resolved after 14dNoNone
Zaidenstein [23]1996F70CABGYesNoL42Resolved after 16dNoNone
Felz [24]1997F50CABGYesNoL56Resolved after 59dNoNone
Mohanty [25]1998M56CABGYesNoL8Resolved after 22dNoAttempted wiring of dehisced sternum on day 9 after diagnosis
Sharpe [26]1999F63CABGNoNoL & M11Resolved after 14dNoNone
Perez [27]1999M68CABG/AVRUKUKL10Resolved after 10dNoNone
Pego-Fernandez [28]1999M38CABGYesNoL90Resolved after 17dNoNone
Kelly [29]2000M77CABGYesNoL18Resolved after 14dYesNone
Fahimi [30]2001M49CABGYesNoLUKFailed after 14dNoL VATS-fibrin glue
Fahimi [30]2001M51CABGYesNoLUKResolved after 14dNoNone
Brancaccio [31]2001M64CABGYesNoL6Resolved after 11dNoNone
Abid [32]2003M58CABGYesNoL3Failed after 8dNoTalc slurry pleurodesis
Riquet [33]2004F59CABGYesNoLUKFailed after 78dNoL thoracotomy-ligation at injury
Gabbieri [34]2004F67CABGYesNoL10Resolved after 28dYesNone
Kilic [35]2005F66CABGYesNoL12Resolved after 10dYesNone
Falode [36]2005F68CABG/ASDYesNoL3Failed after 60dNoL VATS-dry talc pleurodesis
Barbetakis [37]2005M78CABGYesNoL27Resolved after 13dYesNone
Halldorsson [38]2006F47CABGNoNoR10Resolved after 10dNoNone
Choong [39]2006M63CABGYesNoL2Failed after 35dNoR thoracotomy-ligation at diaphragm
Narayan [40]2007F65CABG/MVRYesNoUK1Failed after 3dYesMedian sternotomy-ligation at injury
Paul [41]2009M65CABGUKUKLUKFailed after 14dUKR thoracotomy-thoracic duct ligation
Karimi [42]2010M53CABGYesNoL2Resolved after 27dNoNone
Deguchi [43]2013F78CABGYesYesR3Failed after 10dYesMedian sternotomy-ligation at injury
Altun [44]2015M60CABGYesNoUK2Resolved after 13dYesNone
Altun [44]2015M46CABGYesNoUK3Resolved after 14dYesNone
Owais [45]2015F76CABGYesNoL15Resolved after 7dYesNone
Sabzi [7]2017M43CABGYesNoL0Resolved after 10dNoNone

Abbreviations: M = Male, F = Female, ITA = internal thoracic artery, L = Left, R = Right, M = Mediastinum, UK = Unknown, POD = “post-operative day” when chylothorax was diagnosed, d = days, tx = treatment, CABG = coronary artery bypass graft, MVR = mitral valve replacement, AVR = Aortic Valve Replacement, ASD = Atrial Septal Defect repair, VATS = video-assisted thoracoscopic surgery

An updated adaptation from Halldorsson [38] and Deguchi [43]

Reported cases of chylothorax diagnosed after coronary artery bypass grafting Abbreviations: M = Male, F = Female, ITA = internal thoracic artery, L = Left, R = Right, M = Mediastinum, UK = Unknown, POD = “post-operative day” when chylothorax was diagnosed, d = days, tx = treatment, CABG = coronary artery bypass graft, MVR = mitral valve replacement, AVR = Aortic Valve Replacement, ASD = Atrial Septal Defect repair, VATS = video-assisted thoracoscopic surgery An updated adaptation from Halldorsson [38] and Deguchi [43] Management of post-operative chylothorax starts with conservative measures, including chest tube for effusion drainage. Efforts to decrease chyle production include a trial of low-fat diet with medium-chain triglycerides (absorbed directly into portal system) with transition to TPN and somatostatin or octreotide if output remains high [8]. Conservative management has failed if output exceeds 1 L/day for five days; drainage persists for more than fourteen days; or nutritional status declines. Of the 41 prior cases with post-CABG chylothorax, 26 (63.4%) succeeded with conservative management with all but one resolving in less than 30 days; the other 15 (36.6%) underwent surgery after a median (range) of 14 (3–78) days. In our patient’s case, conservative measures with pigtail catheter drainage and low-fat diet were initially successful at reducing chylous drainage during the first four days of management; however, drainage increased by the fifth day of management likely due to a malfunction of the catheter. Additional conservative measures (chest tube drainage, total parenteral nutrition, and octreotide while nil per os) were continued for an additional 14 days before attempting lymphangiogram; of the 26 reported post-CABG chylothoraces that resolved without surgical intervention, 14 (53.8%) required 14–28 days of conservative management before resolving (see Table 1). When conservative management fails, thoracoscopic or open thoracic duct ligation with chemical pleurodesis can be done [9]. In chylothorax management at our medical center, it is institutional practice to start with lymphangiogram and minimally-invasive thoracic duct embolization before attempting surgical thoracic duct ligation as our Department of Interventional Radiology has a history of success with the less invasive procedure; in the event that duct embolization fails, lymphangiogram may guide future surgical measures. In our patient’s case, the lymphangiogram guided the surgical team to attempt pleurodesis without thoracic duct ligation since the thoracic duct was not identified. Although this is the second report, to our knowledge, of post-CABG yellow nail syndrome, it is possible that the other YNS features (yellow nails and lymphedema) have previously been missed in patients with post-CABG chylothorax since the findings are subtle. Other cases may have been misdiagnosed as fungal infections. In our patient’s case, the close temporal association between the development of chylothorax and appearance of yellow nail discoloration and the temporal proximity of their resolution were more consistent with YNS. Furthermore, the appearance of his nails was less consistent with onychomycosis. Other than yellow discoloration, his nails had no disfiguring features such as thickening, chipping, or separation from the nail bed; his nails also demonstrated a uniform yellow discoloration without black debris. Overall, the appearance of his nails was not consistent with any of the major subtypes of onychomycosis (such as distal and lateral subungual; proximal subungual; endonyx subungual; superficial; or total dystrophic onychomycosis) [10]. Although diagnosing YNS does not alter management, we propose that concurrence of chylothorax with yellow nails and/or lymphedema may suggest predisposition to impaired lymphatic drainage and serve as a marker of degree of lymphatic leakage, portending a difficult recovery course and potentially indicating need for surgical intervention. As our patient’s recovery was challenging (failing conservative treatment and requiring both talc and doxycycline pleurodeses), it is possible that he had a lymphatic aberrancy predisposing to YNS, with intraoperative thoracic duct injury serving as the second insult that caused YNS to manifest clinically.

Conclusions

Chylothorax as a complication of coronary artery bypass grafting is rare, with the most likely mechanism being iatrogenic injury to the thoracic duct or collateral lymphatic vessels. During management of post-operative chylothorax, diagnosis of yellow nail syndrome (through concurrent presence of yellow nail discoloration and/or lymphedema) may suggest a predisposition to impaired lymphatic drainage, potentially indicating the need for surgical management.
  42 in total

1.  A minimally invasive approach to chylopericardium after coronary artery surgery.

Authors:  D A Sharpe; M D Pullen; J P McGoldrick
Journal:  Ann Thorac Surg       Date:  1999-09       Impact factor: 4.330

Review 2.  Chylothorax after myocardial revascularization with the left internal thoracic artery.

Authors:  P M Pêgo-Fernandes; G X Ebaid; G H Nouer; R T Munhoz; F B Jatene; A D Jatene
Journal:  Arq Bras Cardiol       Date:  1999-10       Impact factor: 2.000

3.  Chylothorax: a complication after internal thoracic artery harvesting.

Authors:  G Brancaccio; E Prifti; A M Cricco; M Totaro; A Antonazzo; F Miraldi
Journal:  Ital Heart J       Date:  2001-07

4.  Successful octreotide treatment of chylothorax following coronary artery bypass grafting procedure. A case report and review of the literature.

Authors:  Nikolaos Barbetakis; Theocharis Xenikakis; Andreas Efstathiou; Ioannis Fessatidis
Journal:  Hellenic J Cardiol       Date:  2006 Mar-Apr

5.  Chylothorax after coronary artery bypass and internal mammary artery harvesting: a case report.

Authors:  A Karimi; A SalehiOmran; P Yazdanifard
Journal:  East Mediterr Health J       Date:  2010-10       Impact factor: 1.628

6.  Conservative management of chylothorax after coronary artery bypass grafting.

Authors:  Gokalp Altun; Zerrin Pulathan; Dilek Kutanis; Dogus Hemsinli; Engin Erturk; Ali Civelek
Journal:  Tex Heart Inst J       Date:  2015-04-01

7.  Chylothorax.

Authors:  M K Wood; D J Ullyot
Journal:  J Thorac Cardiovasc Surg       Date:  1994-12       Impact factor: 5.209

8.  Chylothorax after myocardial revascularization with internal mammary graft.

Authors:  D O Weber; P D Mastro; M D Yarnoz
Journal:  Ann Thorac Surg       Date:  1981-11       Impact factor: 4.330

Review 9.  Onychomycosis: Current trends in diagnosis and treatment.

Authors:  Dyanne P Westerberg; Michael J Voyack
Journal:  Am Fam Physician       Date:  2013-12-01       Impact factor: 3.292

Review 10.  Chylothorax as a complication of aortocoronary bypass. Two case reports and a review of the literature.

Authors:  B J Zakhour; M H Drucker; A A Franco
Journal:  Scand J Thorac Cardiovasc Surg       Date:  1988
View more
  1 in total

1.  Nails: The Window to the Nose? Update on Yellow Nail Syndrome.

Authors:  Laura Vollono; Marco Adriano Chessa; Antonio Bruno; Michela Starace; Aurora Alessandrini; Bianca Maria Piraccini
Journal:  Dermatol Pract Concept       Date:  2020-04-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.